Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$734.97 20.94 (2.77%) as of 4:30 Fri 5/3


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 703.06(B)
Last Volume: 4,591,951 Avg Vol: 3,291,238
52 Week Range: $423.21 - $792.28
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 435,750 871,420 2,731,506 6,211,418
Total Sell Value $330,574,311 $608,633,217 $2,147,483,647 $2,147,483,647
Total People Sold 2 2 5 6
Total Sell Transactions 5 14 44 89
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 306
  Page 8 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-29 4 S $292.37 $1,269,254 D/D (4,341) 106,156,686 -5%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-28 4 S $292.16 $2,202,264 D/D (7,538) 106,161,027 -3%     
   Fyrwald J Erik Director   –       •      –    2022-03-21 4 A $289.64 $9,848 D/D 34 69,170     -
   Johnson Kimberly H Director   –       •      –    2022-03-21 4 A $289.64 $9,558 D/D 33 1,170     -
   Greene Gabrielle E Director   –       •      –    2022-03-21 4 A $289.64 $9,848 D/D 34 798     -
   Alvarez Ralph Director   –       •      –    2022-03-21 4 A $289.64 $11,296 D/D 39 51,416     -
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-21 4 S $292.41 $10,306,604 D/D (35,245) 106,168,565 -14%     
   Luciano Juan R Director   –       •      –    2022-03-21 4 A $289.64 $12,455 D/D 43 13,684     -
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-18 4 S $287.56 $60,518,363 D/D (210,000) 106,203,810 -15%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-17 4 S $283.06 $62,435,453 D/D (220,000) 106,413,810 -15%     
   Jonsson Patrik SVP&Pres, LLY Imm, LLY USA&CCO   •       –      –    2022-03-17 4 AS $277.20 $186,556 D/D (673) 31,362 15%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-15 4 S $271.04 $60,511,869 D/D (220,075) 106,633,810 -20%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-14 4 S $269.21 $46,626,915 D/D (173,085) 106,853,885 -22%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-11 4 S $269.05 $5,875,986 D/D (21,840) 107,026,970 -23%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-10 4 S $266.29 $49,287,539 D/D (184,982) 107,048,810 -21%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-09 4 S $266.38 $5,335,148 D/D (20,018) 107,233,792 -24%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-04 4 S $260.69 $55,070,947 D/D (210,000) 107,253,810 -24%     
   Runge Marschall S Director   –       •      –    2022-03-01 4 B $246.78 $49,850 D/D 202 15,436 2.39 33%     
   Jonsson Patrik SVP&Pres, LLY Imm, LLY USA&CCO   •       –      –    2022-03-01 4 AS $247.56 $167,103 D/D (675) 32,035 33%     
   Hakim Anat SVP, GC & Secretary   •       –      –    2022-03-01 4 D $249.95 $874,825 D/D (3,500) 8,864     -
   Hakim Anat SVP, GC & Secretary   •       –      –    2022-03-01 4 OE $0.00 $0 D/D 7,929 12,364     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2022-02-25 4 AS $243.84 $404,774 D/D (1,660) 7,274 31%     
   Luciano Juan R Director   –       •      –    2022-02-22 4 A $239.13 $12,674 D/D 53 13,591     -
   Fyrwald J Erik Director   –       •      –    2022-02-22 4 A $239.13 $9,804 D/D 41 68,883     -
   Greene Gabrielle E Director   –       •      –    2022-02-22 4 A $239.13 $9,804 D/D 41 761     -
  306 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us